Václav Šeda - Concepedia

Author

Václav Šeda

Masaryk University ORCID

Also Known As

V. Seda, V. Šeda, Vaclav Seda, Václav Šeda

Publications

646

Citations

H-Index

Concepts

All Affiliations

Masaryk University Central European Institute of Technology – Masaryk University University Hospital Brno Central European Institute of Technology Dana-Farber Cancer Institute

VŠ

About

Václav Šeda is an author at Masaryk University specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	116
2	Cell Biology	3	3	116
3	Immunology	2	2	97
4	Cell Signaling	2	2	54
5	Gene Expression	1	1	62

Václav Šeda

Publications

417

Citations

H-Index

Page 1

	Year	Citations
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis Gabriela Mladonická Pavlasová, Marek Borský, Václav Šeda, Blood	2016	106
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels Kateřina Musilová, Ján Deván, Kateřina Amruz Černá, Blood	2018	72
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells Kateřina Amruz Černá, Jan Oppelt, Václav Chochola, Leukemia Hematological MalignancyMalignant Blood DisorderImmunologyMicrorna DetectionDna Damage Response	2018	62
<i>miR-29</i> modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors Sonali Sharma, Gabriela Mladonická Pavlasová, Václav Šeda, Blood	2021	56
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels Gabriela Mladonická Pavlasová, Marek Borský, Veronika Svobodová, Leukemia Lymphoid NeoplasiaSignal TransductionCell RegulationIntra-clonal BcrProficient Cll Subpopulation	2018	35
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia Václav Šeda, Eva Vojáčková, Laura Ondrišová, Blood	2021	33
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells Miroslav Boudný, Jana Zemanová, Prashant Khirsariya, Haematologica	2019	24
TGF-β1 signaling plays a dominant role in the crosstalk between TGF-β1 and the aryl hydrocarbon receptor ligand in prostate epithelial cells Andrea Staršíchová, Eva Hrubá, Eva Slabáková, Cellular Signalling Tgf-β1 SignalingUrologySignal TransductionSignaling PathwayReceptor Tyrosine Kinase	2012	19
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia Laura Ondrišová, Václav Šeda, Krystof Hlavac, Journal of Clinical Investigation	2024	10

Page 1